tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Eagle Pharmaceuticals's activity chart (see below) currently has 93 price targets and 68 ratings on display.
Analysts average stock forecasts to be materialized ratio is 70.73% with an average time for these price targets to be met of 163 days.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 09-Aug-2023. First documented stock forecast 10-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Oct-2018
$17
$16 (1600.00%)
$26
3 years 2 months 19 days ago
(09-Aug-2023)
9/15 (60%)
$-2.23 (-11.60%)
52
Hold Since 02-Mar-2020
$33
$32 (3200.00%)
$37
3 years 7 months 15 days ago
(13-Mar-2023)
5/6 (83.33%)
$7.49 (29.36%)
60
Buy Since 08-Dec-2015
4 years 7 months ago
(28-Mar-2022)
1/2 (50%)
$46.76 (113.39%)
395
Buy Since 06-Jan-2016
$57
$56 (5600.00%)
$59
6 years 2 months 17 days ago
(11-Aug-2020)
7/11 (63.64%)
$13.88 (32.19%)
177
Hold Since 22-Mar-2019
$41
$40 (4000.00%)
$52
7 years 7 months 6 days ago
(22-Mar-2019)
29/30 (96.67%)
$-6.15 (-13.04%)
131
What is EGRX (Eagle Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on EGRX (Eagle Pharmaceuticals)?
Which analyst has the current lower performing score on EGRX (Eagle Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most bullish on EGRX (Eagle Pharmaceuticals)?
Which analyst is the currently most reserved on EGRX (Eagle Pharmaceuticals)?
